What’s the State-of-the-Art in Stem Cell?

Event Information

Share this event

Date and Time

Location

Location

Germantown Innovation Center

20271 Goldenrod Lane

#2nd Floor

Germantown, MD 20876

View Map

Event description

Description

Please join us for an informal business discussion over a light lunch about the current state of the Stem Cell/Regenerative Medicine Industry! We'll cover emerging opportunities and challenges in this field and how the MD Stem Cell Research Fund has helped advance stem cell research, commercialization and cures. If you are a life sciences professional, stem cell scientist/entrepreneur or work for a stem cell company you will want to participate in this event.

The Maryland Stem Cell Research Fund (MSCRF) is focused on identifying and fostering cutting-edge research and innovation in the field of regenerative medicine in MD. Their Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland. MSCRF has invested over $155 million in accelerating stem cell research, cures and commercialization, in addition to building a collaborative stem cell community in our region. Learn more about their mission and funding opportunities at www.mscrf.org.

Special panelist guests will be Dr. William Rust from Seraxis and Dr. Mukesh Kumar from AKAN.

This event is free. A light lunch will be served so kindly RSVP and update your RSVP should your plans change. Parking is free in the GIC parking lot. This event is for professionals working in the stem cell industry only, specific medical advice will not be given.

About the Speakers

Dr. Jaishankar is the Associate Director of the MD Stem Cell Research Fund (MSCRF). In this role, Amritha is responsible for MSCRF business development, scientific management and oversight of portfolio ($156million, 460 projects to date). She works with stem cell scientists across Maryland to develop a collaborative research program and promote commercialization of stem cell technologies. Amritha brings over 14 years of experience in stem cell research and program management in federal, academic, and industry settings. She is passionate about using stem cell technologies to accelerate cures for patients in need.

William L. Rust, Ph.D. serves as Seraxis CEO and President. He developed the company’s technological assets and strategy. Prior to launching Seraxis, Dr. Rust lead a number of high performing teams and was instrumental in the development of therapeutic pancreatic and cardiac cells from embryonic stem cells in one of the early laboratories to take this approach. From previous managerial positions in the industry, he has a history of delivering results, meeting corporate milestones and growing company operations. Dr. Rust is a forward thinker and visionary and, after 17 years experience, is well connected in the field of stem cells and regenerative medicine.

Dr. Mukesh Kumar is a Washington DC-based consultant in regulatory affairs and quality assurance for manufacturers and developers of pharma and biotech products. He has been involved in more than 100 multi-national clinical trials, has made hundreds of submissions to the US FDA, EMA, and regulators in more than 40 countries. He has arranged a number of meetings with the US FDA. He has created and led numerous teams for development of pharmaceutical, biotech and medical device products all the way from early stage development to commercial markets. He has conducted GCP, GLP, GMP and GACP audits in the US and several countries in Europe, South America and Asia. He has conducted hundreds of training workshops and has authored numerous peer-reviewed high impact articles on healthcare regulations. He is a frequent consultant to investment companies, government policy think-tanks, social media enterprises, and international business corporations. He is a well known expert in global regulatory affairs and has been an invited speaker at several professional and academic organizations worldwide. He is a visiting professor at George Washington University, Washington DC, and Montgomery College, Maryland. Dr Kumar is PhD in Biochemistry and is a certified regulatory affairs professional by the Regulatory Affairs Professional Society, USA.


Date and Time

Location

Germantown Innovation Center

20271 Goldenrod Lane

#2nd Floor

Germantown, MD 20876

View Map

Save This Event

Event Saved